REFERENCES
- Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008;31:325–330.
- Worls Health Organization (WHO). Environmental Health Criteria 236: Principles and methods for assessing autoimmunity associated with exposure to chemicals. Geneva: WHO Press; 2006; http://www.who.int/ipcs/publications/ehc/ehc236.pdf.
- Tsai S, Santamaria P. MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity. Front Immunol 2013;4:321.
- Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002;2:156–162.
- von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile. Nat Rev Microbiol 2003;1:151–157.
- Christen U, Hintermann E, Holdener M, von Herrath MG. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty? J Autoimmun 2010;34:38–44.
- Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 2012;42:102–111.
- Hyoty H, Kondrashova A. Role of viruses and othe microbes in the pathogenesis of type 1 diabetes. Int Rev Immunol 2014;33:284–295.
- Libbey JE, Cusick MF, Fujinami RS. Role of Pathogens in Multiple Sclerosis. Int Rev Immunol 2014;33:266–283.
- Christen U, Hintermann E. Pathogen infection as a possible cause for autoimmune hepatitis. Int Rev Immunol 2014;33:296–313.
- Fleming JO, Isaak A, Lee JE, Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler 2011;17:743–754.
- Cunningham MW. Rheumatic fever, autoimmunity and molecular mimicry: The streptococcal connection. Int Rev Immunol 2014;33:314–329.
- Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: A true case of molecular mimicry. Trends Immunol 2004;25:61–66.
- Caza T, Oaks Z, Perl A. Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus. Int Rev Immunol 2014;33:330–363.
- Christen U, von Herrath MG. Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference? Cell Mol Immunol 2011;8:193–198.